The Dual RAF/MEK Inhibitor CH5126766/RO5126766 May Be a Potential Therapy for RAS-Mutated Tumor Cells
Makoto Wada, Toshiyuki Sakai(Kyoto Prefectural University of Medicine)
Cited by 48
Related Papers
Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8
|International Journal of Oncology|2013|88
Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer
|Cell Death and Disease|2016|53
Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)‐reactivating agents enhance efficacy of 5‐fluorouracil on human colon cancer cells
|Cancer Science|2013|49
A novel HDAC inhibitor OBP-801 and a PI3K inhibitor LY294002 synergistically induce apoptosis via the suppression of survivin and XIAP in renal cell carcinoma
|International Journal of Oncology|2013|48